Natixis Investment Managers International Exact Sciences Corp Transaction History
Natixis Investment Managers International
- $1.39 Billion
- Q3 2024
A detailed history of Natixis Investment Managers International transactions in Exact Sciences Corp stock. As of the latest transaction made, Natixis Investment Managers International holds 1,855 shares of EXAS stock, worth $114,434. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,855
Previous 2,323
20.15%
Holding current value
$114,434
Previous $98,000
28.57%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.1 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$977 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$884 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$744 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$412 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...